Synthesis and single crystal X-ray analysis of two griseofulvin metabolites

Tetrahedron Letters

Volumn 51, Issue 45, 2010, Pages 5881-5882

  Rønnest, Mads H ^a   Harris, Pernille ^a   Gotfredsen, Charlotte H ^a   Larsen, Thomas O ^a   Clausen, Mads H ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Griseofulvin; Metabolites; Synthesis; X ray structures

Indexed keywords

4 O NORGRISEOFULVIN; 6 O NORGRISEOFULVIN; ANTIFUNGAL AGENT; DRUG METABOLITE; GRISEOFULVIN; PHENOL DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CRYSTAL STRUCTURE; DRUG STRUCTURE; DRUG SYNTHESIS; FLUORESCENCE SPECTROSCOPY; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 77957795357     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2010.08.095     Document Type: Article

References (25)

1. A.E. Oxford, H. Raistrick, and P. Simonart Biochem. J. 33 1939 240
2. J.C. Gentles Nature 182 1958 476
3. K.C.L. Dauk, E. Comrov, J.L. Blumer, M.A. O'Riordan, and L.M. Furman Clin. Pediatr. 49 2010 280
4. A.K. Gupta, J.V. Williams, M. Zaman, and J. Singh Med. Mycol. 47 2009 796
5. Y.S. Ho, J.S. Duh, J.H. Jeng, Y.J. Wang, Y.C. Liang, C.H. Lin, C.J. Tseng, C.F. Yu, R.J. Chen, and J.K. Lin Int. J. Cancer 91 2001 393
6. D. Panda, K. Rathinasamy, M.K. Santra, and L. Wilson Proc. Natl. Acad. Sci. U.S.A. 102 2005 9878
7. B. Rebacz, T.O. Larsen, M.H. Clausen, M.H. Rønnest, H. Löffler, A.D. Ho, and A. Krämer Cancer Res. 67 2007 6342
8. H. Jin, A. Yamashita, S. Maekawa, P.T. Yang, L.M. He, S. Takayanagi, T. Wakita, N. Sakamoto, N. Enomoto, and M. Ito Hepatol. Res. 38 2008 909
9. S.V. Dalvi, and R.N. Dave Ind. Eng. Chem. Res. 48 2009 7581
10. R.L. Chang, N. Zampaglione, and C. Lin Drug Metab. Dispos. 3 1975 487
11. B. Boothroyd, E.J. Napier, and G.A. Somerfield Biochem. J. 80 1961 34
12. S. Symchowi, and K.K. Wong Biochem. Pharmacol. 15 1966 1595
13. C. Lin, J. Magat, S. Symchowi, and R. Chang J. Pharm. Pharmacol. 24 1972 911
14. M.J. Barnes, and B. Boothroyd Biochem. J. 78 1961 41
15. P.A. Harris, and S. Riegelma J. Pharm. Pharmacol. 58 1969 93
16. W.L. Chiou, and S. Riegelma J. Pharm. Pharmacol. 60 1971 1376
17. C.C. Lin, J. Magat, R. Chang, J. Mcglotte, and S. Symchowi J. Pharmacol. Exp. Ther. 187 1973 415
18. L.A. Duncanson, J.F. Grove, J. Macmillan, and T.P.C. Mulholland J. Chem. Soc. 1957 3555
19. J.F. Grove, J. Macmillan, T.P.C. Mulholland, and M.A.T. Rogers J. Chem. Soc. 1952 3949
20. S.G. Levine, and E.H. Ronald J. Org. Chem. 40 1975 2540
21. B.H. Arison, N.L. Wendler, D. Taub, R.D. Hoffsommer, C.H. Kuo, H.L. Slates, and N.R. Trenner J. Am. Chem. Soc. 85 1963 627
22. V. Arkley, G.I. Gregory, J. Attenbur, and T. Walker J. Chem. Soc. 1962 1260
23. 3CN (isocratic run at 65:35, for 15 min) as the mobile phase to yield 2 (2.8 mg, 29%) as a yellow oil, which was crystallized from EtOAc and heptane.
24. Crystallographic data (excluding structure factors) for the structures in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication nos. CCDC 775177 (2) and CCDC 775176 (3). Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax: +44 (0)1223 336033 or email: deposit@ccdc.cam.ac.uk ).
25. E. Townley, and P. Roden J. Pharm. Sci. 69 1980 523